|
Novartis (NVS): 'Best pipeline in the business'
2008-07-03 05:00:00 "The pipelines of most Big Pharmas are bone dry; last year, the FDA approved the lowest number of new drugs (19) since 1983," notes Louis Basenese (http://www.thestockadvisors.co-m/ccount/click.php?id=2135), contributing editor to the industry-leading The Oxford Club (http://www.thestockadvisors.co-m/ccount/click.php?id=2135)."Bu-t opportunity always lurks in the wreckage, and one Big Pharma, in particular, is being unfairly punished." Here's his bullish outlook on Novartis (http://www.thestockadvisors.co-m/quote.htm?sym=nvs) (NYSE: NVS (http://www.thestockadvisors.co-m/quote.htm?sym=nvs)), which he calls the "only Big Pharma worth owning.""Unlike others in the sector, Novartis doesn't suffer from an empty pipeline. It's launched more drugs globally than any other firm in the past seven years. It has more than 100 projects in phase II (or later) trials. And it expects to file at least six new drug applications this year alone. "Plus, its products cover all bases, from vaccine...
Novartis: Latest Victim Of U.S. Economy
2008-01-18 02:43:00 Weakness in the U.S. economy is seeping into most all businesses, even Swiss pharmaceutical company, Novartis. Novartis (nyse: NVS - news - people ) released its fourth-quarter and full-year results on Thursday, and blamed its 42.0% profit decline on weak performance in the U.S. and restructuring costs. The company said that cutting 2,500 jobs worldwide resulted ...
By: Business News
Novartis to Cut 2,500 Jobs by 2010
2007-12-14 08:56:00 San Francisco Gate - Article:Novartis to Cut 2,500 Jobs by 2010:/n/a/2007/12/13/financial/-f040927S02.DTL … The Basel-based pharmaceutical said Thursday it would focus on engineering new drugs.... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]
By: Engineers Voice
Novartis to Cut 2,500 Jobs by 2010
2007-12-14 08:55:00 San Francisco Gate - Article:Novartis to Cut 2,500 Jobs by 2010:/n/a/2007/12/13/financial/-f040927S02.DTL … The Basel-based pharmaceutical said Thursday it would focus on engineering new drugs.... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]
By: Engineers Voice
Swiss drugmaker Novartis to cut 2,500 jobs
2007-12-14 02:21:00 Swiss drugmaker Novartis said Thursday it plans to cut 2,500 jobs in a restructuring programme aimed at generating yearly cost savings of 1.6 billion dollars (1.1 billion euros). Many of the cuts, which will take place in 2008 and 2009, will be achieved through normal fluctuation in staffing levels and social programmes, a statement said. The ...
Today's Pick: Novartis India (Rs 348.10)
2007-11-20 20:29:00 We recommend a buy in Novartis India at current price levels. The stock had been on a long-term downtrend from December 2004 high of Rs 700 levels to August 2007 low of Rs 270. We note that the long-term downtrend got arrested at a significant ... 3 Vote(s)
By: Market Buzz
Novartis India Limited
2007-09-17 08:41:00 *Novartis India Limited Target 520* ** *Parent support and new launches to drive growth:* Novartis India enjoys the support of its strong parent Novartis AG, which is one of the fastest growing top 10 pharmaceutical companies in the world with revenues to the tune of US$ 37 bn (2006). The top ten products generated revenues ...
HEALTH-INDIA: Activists Will Continue to Push Boycott of Novartis
2007-08-27 10:15:00 BANGALORE, Aug 27 (IPS) - Activist groups campaigning for affordable drugs will continue their boycott campaign against Swiss pharma major Novartis AG, whose controversial petition arguing that Indian patent laws violated World Trade Organisation (WTO) provisions was rejected by the Madras High Court in southern Chennai city.
By: Commodity Wealth
UPDATE 1-US warns Novartis on Alzheimer's drug promotion - Reuters
2007-08-26 03:08:00 UPDATE 1-US warns Novartis on Alzheimer's drug promotionReuters -Aug 14, 2007VX: Quote, Profile, Research) promotion for Alzheimer's drug Exelon used misleading claims about the product's effectiveness and risks, US health officials … More: continued here
US warns Novartis on Alzheimer's drug promotion - Reuters.uk
2007-08-16 04:08:00 US warns Novartis on Alzheimer's drug promotionReuters.uk, UK-60;-Aug 14, 2007WASHINGTON (Reuters) - A Novartis AG promotion for Alzheimer's drug Exelon made misleading claims about the medicine's effectiveness and risks, …UPDATE 1-US warns Novartis on Alzheimer's drug promotionReutersFDA warns Novartis over misleading information on ExelonPharma Times (subscription)all 15 news articles More: continued here
US warns Novartis on Alzheimer's drug promotion - Reuters
2007-08-15 02:08:00 US warns Novartis on Alzheimer's drug promotionReuters -46 minutes agoVX: Quote, Profile, Research) promotion for Alzheimer's drug Exelon used misleading claims about the product's effectiveness and risks, US health officials … More: continued here
US FDA warns Novartis on Alzheimer's drug promotion - Reuters
2007-08-14 23:08:00 US FDA warns Novartis on Alzheimer's drug promotionReuters -10 minutes agoVX: Quote, Profile, Research) promotion for Alzheimer's drug Exelon used misleading claims about the product's effectiveness and risks, US health officials … More: continued here
What do we need to know about the Novartis case decided by the Madras High
2007-08-10 12:28:00 The media has reported just a few days back about the Madras High Court striking down a case filed by the pharma major Novartis about India?s patent regime not being compliant with TRIPS regime of the WTO. Novartis being a Swiss pharma major and that too when a Swiss dignitary was visiting India, there was all round expectation that the Swiss authorities would pressure the Indian government on behalf of Novartis. But no such thing happened and the very next day the Union Minister of Commerce and Trade Mr. Kamal Nath was clarifying that no other country has a grouse against India?s Intellectual Property Regime. The visiting Swiss federal councilor Doris Leuthard was also quoted as saying ?We have to accept the settlement and the Swiss government never engages itself or questions any judicial announcements.? What exactly was at stake in the case? Novartis manufactures a drug called Glivec, which is used for treatment of cancer. It was granted patent for this by India in 19...
By: Discover It
Buenas noticias - La India desestima la demanda de Novartis
2007-08-07 23:01:00 Hace unos meses, la farmacéutica Novartis solicitó en la India una patente sobre una fórmula mejorada del fármaco Glivec, uno de sus anticancerígenos más importantes.Sin embargo, la solicitud fue rechazada, ya que la Ley de Patentes de 2005 del país sólo protege los fármacos que se consideran verdaderas innovaciones médicas (y no mejoras de medicamentos existentes). Novartis apeló la decisión alegando que ésta iba en contra de los acuerdos de la OMC sobre Derechos de Propiedad Intelectual y Comercio.Como ya hemos comentado en alguna ocasión, la legislación india ha permitido que este país se convierta en uno de los fabricantes de genéricos más importantes del Planeta, del que depende además la salud de países que no pueden permitirse el elevado coste de los medicamentos "de marca". Una sentencia favorable a la farmacéutica habría puesto en peligro el acceso a los fármacos esenciales contra el sida de los pacientes del país y buena parte de África, como advi...
By: Ciencia y Lejos
Maalox, Gasx, Exlax - Free + Tax - Novartis Walgreens Deal
2007-08-04 08:14:00 Rating: 0 Posted By: NickHumphrey Views: 49 Replies: 0 I don't know if this coupon is printing out nation wide or not, but in Grand Rapids, MI, when I buy a pack of gasx, either strips or 18 ct. chewables, I get a catalina that prints out for $3 off the purchase of two Gasx 18ct Chewables or the strips.Step 1:5 products in any combination of Gasx, Maalox, or Exlax that are on sale for $5 ea. One has to be Gasx.Then use the Easy Saver catalog to get $10 off of your purchase (5 - $2 coupons)This will be $15 + tax OOP, $12 Register Rewards will print out + a coupon for $3 off 2 Gasx strips or 18ct. chewablesStep 2 (Do this step until the end of gasx stock / manger kicks you out):Buy 2 gasx strips or 18 ct. chewablesBuy 3 maalox / exlaxTotal after Easy saver will be $15, use the Gasx coupon and the $12 RR and all that will be left to pay is the tax.I have done this about 20 times earlier this week, and back then I never did more then 2-3 times per store, during the day when they are...
Novartis celebrates US approval of new Alzheimer's treatment - England?s No
2007-07-16 20:07:00 England's Northwest Novartis celebrates US approval of new Alzheimer's treatmentEngland’s Northwest, UK -12 minutes agoA new treatment for Alzheimer's disease made by a company with a base in the northwest of England has gained approval in the US. The once-daily Exelon Patch … More: continued here
Reader Request - Novartis AG (NYSE:NVS)
2007-07-10 15:00:00 Dividends Matter reader Jason has requested that we have a look at Novartis AG which trades on the NYSE under the symbol NVS. Let’s see if this company is worth adding to our dividend paying portfolio. Company Profile: From Yahoo Finance Novartis AG engages in the research, development, manufacture, and sale of health care products. For a complete ...
By: Dividends Matter
Novartis receives FDA approval for Exelon patch for Alzheimer's ? - CNNMone
2007-07-09 11:07:00 Novartis receives FDA approval for Exelon patch for Alzheimer's…CNNMoney.-com -37 minutes ago… approval from the US Food and Drug Administration (FDA) for its Exelon (NYSE:EXC) Patch for the treatment of mild to moderate Alzheimer's disease. …Exelon(R)Patch, the First and Only Skin Patch for the Treatment of …CNNMoney.comNovartis gets US approval for Alzheimer patchReutersall 13 news ...
Novartis Gets EU OK for New Flu Vaccine
2007-06-13 19:06:00 BASEL, Switzerland (AP) — Novartis AG has received European Union approval for flu vaccine Optaflu, the Swiss drugmaker said Wednesday…. More: continued here
Nestle confirms $5.5 bln Gerber buy from Novartis (Reuters)
2007-04-12 00:00:00 Nestle SA , the world's largest food company, confirmed a $5.5 billion cash deal to buy U.S. baby-food maker Gerber from Novartis AG , furthering its push into the nutrition business.
By: Commodity Wealth
MIT and Novartis Make Diabetes Genetic Info Freely Available
2007-02-21 15:41:00 The Broad Institute at MIT, Novartis, and Lund University have publicly released the results of a genome-wide map of genetic differences in humans and their relationship to type 2 diabetes and other metabolic disorders. The work is the result of a pioneering public-private collaboration known as the Diabetes Genetics Initiative (DGI), which was formed in 2004 and is aimed at deciphering the genetic causes of type 2 diabetes. The collaboration brings together diverse expertise in diabetes and metabolic disease, human genetics, genomics, statistical analysis, and drug development. The results of the study are freely available online at www.broad.mit.edu/diabetes. First, let me start by saying I'm pretty much a die-hard capitalist, and I believe that profit is an excellent motivator for companies in performing research and development. But I don't think that anybody should be allowed to profit off of human suffering, so that's why I'm really happy when I see something like this...
HIV/AIDS Advocates Protest Novartis? Case Challenge India Patent Law
2007-01-30 21:02:02 Some HIV/AIDS advocacy groups are calling on pharmaceutical company Novartis to drop its legal challenge to the Indian government’s patent laws, saying that if the company wins the case it could restrict access to antiretroviral drugs for millions of people worldwide, South Africa’s Business Day reports. Novartis is challenging a section of India’s Patents Act ... |
|
 |
|
 |
